Late treatment study
et al., Ann. Oncol., 2020, Sep, 31, S1026, doi:10.1016/j.annonc.2020.08.1830 (Peer Reviewed)
COVID-19 and lung cancer: What do we know?
Small retrospective study of 22 lung cancer patients, 14 treated with HC
Q+AZ, showing HC
Q+AZ mortality relative risk RR 0.57, p
death, ↓43.0%, p=0.14
Please send us corrections, updates, or comments.